The company is active in 45 countries, with a strongest reputation in Europe and Asia and a growing presence in the United States. “The entry in force of the CPT 2017 reimbursement codebook as of Jan. 1, 2017 is a milestone towards the full acceptance of endoscopic minimally invasive spine surgery techniques,” said Founder and CEO Wolfgang Ries.
The new codebook contains the first endoscopic spine surgery code for transforaminal and/or interlaminar procedures, which the company’s TESSYS and iLESSYS cover. The company received 18 patents and patent publications last year, bringing their total patents and trademarks to 150.
The company’s EndoLIF Cage was introduced for minimally invasive and open transforaminal lumbar interbody fusion and the company expects to innovate with new implants based on the EndoLIF technology in the future. The company will also focus on decompression methods based on endoscopic systems.
More articles on MIS spine:
MIS driving ambulatory surgery center market: 5 insights
Minimally invasive vs. open surgery for adult spinal deformity: 6 key notes on fractional curve
Rush University Medical Center promotes Dr. Kern Singh to full professor
